Polypharmacy: Why Your Grandparents Might Be Taking Too Many Medicines?

Polypharmacy has become an entrenched problem, which describes the simultaneous use of five or more medications in modern geriatric medicine. Multiple medications serve essential purposes in treating complex medical conditions among older adults, but their consumption brings significant dangers. This situation represents the struggle between disease-based prescribing decisions and patient-focused care, and it is made worse by ageing physical systems, multiple health issues, and guidelines that encourage repetition.

1. Multimorbidity and the Accumulation of Drug Burden

Due to their age, elderly patients often have multiple persistent medical conditions, known as multi morbidities, when they have two or more chronic diseases. The combination of seven guideline-based drugs prescribed for a 75-year-old patient with type 2 diabetes mellitus, hypertension, heart failure, osteoarthritis, and cognitive decline creates a massive medicinal load.

Independent specialty-based medication prescriptions lead to the development of the problem. Each specialty profession, such as endocrinology, cardiology, and orthopedics, adopts optimized care regimens independently but does not review total patient therapy for synergies and possible risks. These independent medical prescriptions result in more drug interactions, known as DDIs, and multiple pharmacodynamic effects that lead to various iatrogenic complications for patients.

2. Pharmacokinetic and Pharmacodynamic Vulnerabilities in the Elderly

Elderly patients experience substantial adjustments in drug absorption, distribution, metabolism, and excretion, which requires age-aware therapeutic practices. 

The necessary acidic medium for drugs such as calcium carbonate, iron salts, and certain antifungal drugs faces reduced bioavailability because of decreased splanchnic blood flow and gastric acid secretion.

The total body water reduction, together with decreased lean mass and increased body fat, creates changes to the drug distribution volume (Vd). The deposition of diazepam, amiodarone, and antipsychotic medications in adipose tissue results in a prolonged drug half-life and an increased potential for harmful side effects.

The Phase I enzymatic activities leading to oxidation and reduction show greater impairment in contrast to Phase II conjugation functions. Physical decline in hepatic blood flow, combined with decreased levels of cytochrome P450 enzymes, leads to reduced drug elimination of theophylline, verapamil, and warfarin, which creates higher risks for drug accumulation.

After age 40, renal clearance declines by about 1% each year, even in the absence of overt kidney disease. Creatinine measurements in serum may not reflect muscle loss in aged patients, necessitating the use of eGFR or creatinine clearance (e.g., Cockcroft-Gault) to determine proper medication dosages. Proper adjustment of medications that kidneys eliminate from the body is essential to prevent drug overdose of digoxin, lithium, aminoglycosides, and DOACs.

Pharmacodynamic sensitivity is also heightened. The consumption of benzodiazepines leads to significant cognitive impairment as well as an increased risk of falls, even when taken in small doses. The drug sensitivity of older adults makes them react strongly to anticholinergic agents, so brief exposure to these drugs results in confusion, urinary retention, and risk of delirium.

3. Prescribing Cascades and Diagnostic Oversights

The prescribing cascade stands as a notable yet unidentified reason for polypharmacy. An adverse drug reaction that doctors wrongly identify as a different illness makes them start new treatment without removing existing medications or modifying their doses.

The patient develops peripheral oedema because of a calcium channel blocker treatment, which prompts their physician to start loop diuretics, thus causing electrolyte imbalance and volume depletion.

NSAIDs have a well-known tendency to elevate blood pressure and generate kidney disease progression, yet healthcare providers sometimes mistake these effects in older patients to be natural ageing changes, resulting in aggressive therapeutic interventions and meritless medical testing.

The cascade effect of prescribing multiple medications produces a self-generating loop that interferes with recognizing the root cause and makes patients more vulnerable to adverse effects from multiple medications.

4. The Burden of Inappropriate Medication Use

The Beers Criteria and the STOPP/START guidelines provide established reasoning tools for detecting potentially inappropriate medications (PIMs) in older adult patients. These include:
• Long-acting benzodiazepines (e.g., diazepam)
• Anticholinergics (e.g., amitriptyline, diphenhydramine)
• NSAIDs in patients with CKD or heart failure
• Sliding-scale insulin monotherapy

Clinical practice fails to achieve consistent results even with the existing guidelines in place. PIMs continue residing in therapeutic regimens because healthcare providers hesitate to change medications, do not have enough time to complete medication assessments, or fear disturbing complex medical situations.

5. Therapeutic Prioritization and Deprescribing

The medical benefits achieved through intense disease-specific therapy decrease in value for patients with either a brief remaining lifespan or multiple serious health conditions. Strengthening blood glucose control through multiple drug treatments raises hypoglycemic dangers in treatment-resistant diabetic patients who are elderly and have dementia.

The active process of deprescribing goes beyond passive drug withdrawal since it follows structured, evidence-based guidelines using benefit-risk assessment with patient care objectives while identifying redundant medications. Deprescribing should be an active medical process for healthcare providers, who need to use equal levels of clinical thinking skills and pharmacological expertise when initiating new medications.

Conclusion

Polypharmacy is described more than medication accumulation because it originates from complex issues associated with chronic disease care as well as inadequate attention to age-sensitive pharmacologic risks. Clinicians need to address this problem through a patient-centred method consisting of pharmacotherapy with geriatrics and ethical prescribing practices.

Routine practice of reconciliation, rationalization, and review should become essential elements for managing the healthcare of older adults. Occasionally, the best medication decision involves the deliberate removal of all prescription drugs.

_MSM/SE